Amrish Patel – Trademark Portfolio
Entity Type: 01
Amrish Patel holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 25 (Clothing) across 6 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include WELLZON. The owner is based in Peachtree Corners, GA.
4780 Waterside Parkway
Peachtree Corners, GA 30092
Showing of trademarks Trademarks
Trademark Classifications
Amrish Patel's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Amrish Patel have?
Amrish Patel has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does Amrish Patel file in?
Amrish Patel files trademarks across 6 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 25 (Clothing), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.
What are Amrish Patel's most well-known trademarks?
Amrish Patel's registered trademark portfolio includes well-known marks such as WELLZON. These are among 1 currently registered trademark in the portfolio.
What is Amrish Patel's trademark registration success rate?
Amrish Patel has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.